alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › therapies

therapies

8 studies tagged therapies, dated 2020-06-09 to 2026-06-27. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Potential and biases of large language model simulation for public surveys on Alzheimer's disease therapies 2026-06-27
  2. Optimizing Antibody-Based Therapies for Alzheimer's Disease: From Clinical Limitations to Molecular Engineering Innovations 2026-06-04
  3. [Advances in Anti-Dementia Therapies in Older Adults] 2026-05-29

Studies

8 studies carry this tag.

Date range

2020 to 2026

Top journals

  • Aging and disease 1
  • CNS drugs 1
  • Deutsche medizinische Wochenschrift (1946) 1
  • Frontiers in physiology 1
  • International journal of molecular sciences 1

8 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Potential and biases of large language model simulation for public surveys on Alzheimer's disease therapies

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Journal of Alzheimer's disease : JAD 2026-06-27 Treatments

    BackgroundWhile large language models (LLMs) have a potential to simulate public-opinion, their reliability for sensitive medical topics like novel Alzheimer's disease (AD) treatments remains unclear.

  2. Optimizing Antibody-Based Therapies for Alzheimer's Disease: From Clinical Limitations to Molecular Engineering Innovations

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Aging and disease 2026-06-04 Treatments

    Antibody-based immunotherapy represents one of the most promising disease-modifying strategies for Alzheimer's disease (AD).

  3. [Advances in Anti-Dementia Therapies in Older Adults]

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Deutsche medizinische Wochenschrift (1946) 2026-05-29 Treatments

    The rising prevalence of dementia, driven by demographic aging, underscores the urgent need for effective therapeutic strategies.

  4. Advances in neurological therapies: A review of clinical trials in Alzheimer's, Parkinson's, and multiple sclerosis

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. The American journal of medicine 2025-11-27 Treatments

    The period from 2020 to 2025 marked a pivotal juncture in the treatment of major neurological diseases, with Phase II-IV trials delivering the first compelling evidence for disease-modifying interventions in Alzheimer's disease, Parkinson's disease, and multiple sclerosis.

  5. Favorable long-term cognitive outcomes following recurrent ARIA linked to amyloid-lowering therapies: two cases

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Journal of neurology 2025-01-24 Treatments

    These cases suggest that recurrent ARIA-E do not inevitably lead to accelerated progression, instead, may relate to possible long-term benefits.

  6. Alzheimer's Disease: Combination Therapies and Clinical Trials for Combination Therapy Development

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. CNS drugs 2024-06-27 Treatments

    Alzheimer's disease (AD) is a complex multifaceted disease.

  7. Treatment of Alzheimer's Disease: Beyond Symptomatic Therapies

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. International journal of molecular sciences 2023-09-09 Treatments

    In an ever-increasing aged world, Alzheimer's disease (AD) represents the first cause of dementia and one of the first chronic diseases in elderly people.

  8. Involvement of Lipids in Alzheimer's Disease Pathology and Potential Therapies

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Frontiers in physiology 2020-06-09 Genetics

    Lipids constitute the bulk of the dry mass of the brain and have been associated with healthy function as well as the most common pathological conditions of the brain.

All topic tags with their study counts